Advanced NanoTherapies
Los Gatos, California, United States · Biotechnology, Health Care, Manufacturing
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
Key facts
- Headquarters
- Los Gatos, California, United States
- Employees
- 17
- Industries
- Biotechnology, Health Care, Manufacturing
- Status
- Private
- Website
- http://advancednanotherapies.com
- Company page
Recent activity at Advanced NanoTherapies
- : Advanced NanoTherapies raised over $31M in Series B funding led by S3 Ventures to scale manufacturing and advance clinical trials.
- : Advanced Nanotherapies (Ant) Secures $4M Strategic Investment To Accelerate Clinical Development Of Sirplux Duo Drug-Coated Balloon (Dcb) For Treating De Novo Coronary Artery Disease (Cad)
- : Advanced Nanotherapies Announces Closing Of Oversubscribed $7.2 Million Series A Financing
- : Advanced Nanotherapies
- : Advanced Nanotherapies
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
Advanced NanoTherapies funding history
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Series B | $31.0M |
| Aug 2023 | Seed | $4.0M |
| Jun 2022 | Series A | $7.2M |
| Jan 2022 | Venture | $9.2M |
| Dec 2019 | Seed | $640K |
Leadership
- Regina Groves, Director
- Jerett Creed, Director
- Mehdi Shishehbor, Director
- Phillippe Urbain, Director
- Marwan Berrada-Sounni, Executive Officer, Director
- Michael Mandel, Head of Corporate Development
Verified email and direct lines for Advanced NanoTherapies’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Companies similar to Advanced NanoTherapies
- Drug Development Solutions (An LGC Business Unit) · Biotechnology, Health Care, Manufacturing, Science And Engineering
- PRISYM ID · Biotechnology, Health Care, Manufacturing, Science And Engineering
- Antares Pharma · Biotechnology, Health Care, Manufacturing, Science And Engineering
- Amarna Therapeutics · Biotechnology, Health Care, Manufacturing, Science And Engineering
- RedHill Biopharma Ltd · Biotechnology, Health Care, Manufacturing, Science And Engineering
About Advanced NanoTherapies: questions and answers
What does Advanced NanoTherapies do?
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention. We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
Where is Advanced NanoTherapies headquartered?
Advanced NanoTherapies is headquartered in Los Gatos, California, United States.
How many employees does Advanced NanoTherapies have?
Advanced NanoTherapies has about 17 employees.
Has Advanced NanoTherapies raised funding?
Yes. Fundz has recorded 5 funding events for Advanced NanoTherapies. The most recent, Series B of $31.0M, was in Jun 2026.
What is the latest news on Advanced NanoTherapies?
On Jun 2, 2026, Advanced NanoTherapies raised over $31M in Series B funding led by S3 Ventures to scale manufacturing and advance clinical trials.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy